{"DataElement":{"publicId":"6659292","version":"1","preferredName":"Stage Prognostic Factor Clinical Tumor Size Value","preferredDefinition":"The quantity measured or computed related to the size of a tumor before any treatment.","longName":"6027939v1.0:6659290v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6027939","version":"1","preferredName":"Stage Prognostic Factor Clinical Neoplasm Size","preferredDefinition":"The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body._The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The physical magnitude of something.","longName":"2688190v1.0:6027937v1.0","context":"PS-CC","contextVersion":"1","ObjectClass":{"publicId":"2688190","version":"1","preferredName":"Stage Prognostic Factor","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.:The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","longName":"C16899:C18959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Prognostic Factor","conceptCode":"C18959","definition":"The general personal and health characteristics that have a bearing on the course of a disease and its eventual outcome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C0FC8A1-D62E-5124-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-09","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-10-09","modifiedBy":"ONEDATA","dateModified":"2007-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6027937","version":"1","preferredName":"Clinical Neoplasm Size","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The physical magnitude of something.","longName":"C25398:C3262:C25681","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Size","conceptCode":"C25681","definition":"The physical magnitude of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D95E9F6-A487-2A57-E053-F662850ABD32","latestVersionIndicator":"Yes","beginDate":"2017-11-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-09","modifiedBy":"ONEDATA","dateModified":"2017-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NAACCR:North American Association of Central Cancer Registries","workflowStatus":"RELEASED","registrationStatus":"Application","id":"5D95E9F6-A498-2A57-E053-F662850ABD32","latestVersionIndicator":"Yes","beginDate":"2017-11-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2017-11-09","modifiedBy":"HARTLEYG","dateModified":"2018-11-06","changeDescription":"Curated to support NAACCR v16_11.09.17_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6659290","version":"1","preferredName":"Clinical Tumor Size Value","preferredDefinition":"A numerical quantity measured or assigned or computed.","longName":"6659290v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"<=2.0 cm","valueDescription":"Less than or equal to 2.0 cm","ValueMeaning":{"publicId":"2815250","version":"1","preferredName":"Less than or equal to 2.0 cm","longName":"2815250","preferredDefinition":"A tumor where the greatest dimension is less than or equal to 2.0 centimeters.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Less than or Equal to 2.0 cm","conceptCode":"C120285","definition":"A tumor where the greatest dimension is less than or equal to 2.0 cm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCC9E55-6661-3652-E040-BB89A6431F50","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7E567-BE93-6538-E053-F662850A483F","beginDate":"2008-12-11","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"},{"value":">=2.1 cm","valueDescription":">/= 2.1 cm","ValueMeaning":{"publicId":"2764977","version":"1","preferredName":">/= 2.1 cm","longName":"2764977","preferredDefinition":"A tumor where the greatest dimension is greater than or equal to 2.1 centimeters.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Greater than or Equal to 2.1 cm","conceptCode":"C120286","definition":"A tumor where the greatest dimension is greater than or equal to 2.1 cm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51ABE40E-1711-1AA7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/19/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"83E7E567-BE7E-6538-E053-F662850A483F","beginDate":"2019-03-12","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-03-12","modifiedBy":"ONEDATA","dateModified":"2019-03-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2414933","version":"1","preferredName":"Value","preferredDefinition":"A numerical quantity measured or assigned or computed.","longName":"C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"02772734-9BE5-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-06","modifiedBy":"ONEDATA","dateModified":"2005-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8293447A-F025-494E-E053-F662850A9F88","latestVersionIndicator":"Yes","beginDate":"2019-02-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-23","modifiedBy":"MORENOC","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Clinical Tumor Size","type":"Preferred Question Text","description":"Clinical Tumor Size","url":null,"context":"Alliance"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Clinical tumor size","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"829371EF-9C0A-5644-E053-F662850A02AC","latestVersionIndicator":"Yes","beginDate":"2019-02-23","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-02-23","modifiedBy":"MORENOC","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}